EB-101 (Atlas)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameEB-101 (Atlas)

Drug Alias NameBeta amyloid vaccine (Atlas Pharmaceuticals)

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionBeta amyloid A4 protein modulators

TargetsBeta amyloid A4 protein

Therapy Area/IndicationsAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAtlas Pharmaceuticals Llc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAtlas Pharmaceuticals Llc

Active IndicationsN/A

Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A